Primary immunodeficiency update: Part I. Syndromes associated with eczematous dermatitis.
In the past decade, the availability of powerful molecular techniques has accelerated the pace of discovery of several new primary immunodeficiencies (PIDs) and revealed the biologic basis of other established PIDs. These genetic advances, in turn, have facilitated more precise phenotyping of associated skin and systemic manifestations and provide a unique opportunity to better understand the complex human immunologic response. These continuing medical education articles will provide an update of recent advances in PIDs that may be encountered by dermatologists through their association with eczematous dermatitis, infectious, and non-infectious cutaneous manifestations. Part I will discuss new primary immunodeficiencies that have an eczematous dermatitis. Part II will focus on primary immunodeficiencies that greatly increase susceptibility to fungal infection and the noninfectious presentations of PIDs.
National Institutes of Health, National Cancer Institute, Bethesda, Maryland.
Dominique C
DC
Pichard
National Institute of Allergy and Infectious Disease, Bethesda, Maryland.
Alexandra F
AF
Freeman
National Institutes of Health, National Cancer Institute, Bethesda, Maryland. Electronic address: cowene@mail.nih.gov.
Edward W
EW
Cowen
D015897:Comorbidity; D004485:Eczema / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy*; D004502:Education, Medical, Continuing; D005260:Female; D015316:Genetic Therapy / Q000379:methods; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000175:diagnosis / Q000453:epidemiology* / Q000628:therapy*; D015994:Incidence; D008297:Male; D011379:Prognosis; D018570:Risk Assessment; D012720:Severity of Illness Index; D016896:Treatment Outcome